- Home
- RAPP vs MOV Comparison
RAPP vs MOV Comparison
Compare RAPP & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPP
- MOV
- Stock Information
- Founded
- RAPP 2022
- MOV 1961
- Country
- RAPP United States
- MOV United States
- Employees
- RAPP N/A
- MOV N/A
- Industry
- RAPP
- MOV Consumer Specialties
- Sector
- RAPP
- MOV Consumer Discretionary
- Exchange
- RAPP Nasdaq
- MOV Nasdaq
- Market Cap
- RAPP 450.0M
- MOV 379.1M
- IPO Year
- RAPP 2024
- MOV 1993
- Fundamental
- Price
- RAPP $11.31
- MOV $15.89
- Analyst Decision
- RAPP Strong Buy
- MOV Strong Buy
- Analyst Count
- RAPP 5
- MOV 1
- Target Price
- RAPP $35.00
- MOV $31.50
- AVG Volume (30 Days)
- RAPP 209.3K
- MOV 184.5K
- Earning Date
- RAPP 08-07-2025
- MOV 05-29-2025
- Dividend Yield
- RAPP N/A
- MOV 8.79%
- EPS Growth
- RAPP N/A
- MOV N/A
- EPS
- RAPP N/A
- MOV 0.78
- Revenue
- RAPP N/A
- MOV $650,768,000.00
- Revenue This Year
- RAPP N/A
- MOV $0.71
- Revenue Next Year
- RAPP N/A
- MOV N/A
- P/E Ratio
- RAPP N/A
- MOV $19.53
- Revenue Growth
- RAPP N/A
- MOV N/A
- 52 Week Low
- RAPP $6.43
- MOV $12.85
- 52 Week High
- RAPP $29.74
- MOV $26.59
- Technical
- Relative Strength Index (RSI)
- RAPP N/A
- MOV 49.55
- Support Level
- RAPP N/A
- MOV $14.71
- Resistance Level
- RAPP N/A
- MOV $15.76
- Average True Range (ATR)
- RAPP 0.00
- MOV 0.37
- MACD
- RAPP 0.00
- MOV 0.00
- Stochastic Oscillator
- RAPP 0.00
- MOV 50.59
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.